SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Zwiener who wrote (670)10/17/1997 12:39:00 AM
From: John Zwiener   of 1115
 
By the way, in my last post, I am addressing David's question about AVAX's melanoma vaccine, and not Lidak's vaccine. In lidak's vaccine, their press release isn't all that clear either, but they seem to imply the possibility that 5 of 15 stage 4 melanoma's stabilized and went into remission. This also HAS to be a typo. They can't do both in the same patient if defined the way I understand the terms. stabilization indicates no growth. Partial remission means decrease more than 50%. Remission means complete disappearance by various clinical means. Are they trying to say that they have achieved complete remission in some patients?

Now say that AVAX really does have good results, they would then attach their hapten binded antigen technology to lidak's LMI technology. Also there are many other melanoma vaccines being tried. All of these that I am aware of could be combined with LMI if they had positive results. In a way, Lidak implies this possibility in their press release.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News